HGS1029

· Human Genome Sciences Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HGS1029, covering 2013-08-02 to 2013-08-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of HGS1029 in Subjects With Relapsed or Refractory Lymphoid Malignancies [Phase 1]